Sfoglia per RIVISTA
ONCOTARGET
Collezione AOU San Luigi di Orbassano

  

Items : 7

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. in Oncotarget / Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Iurlo A; Nobili A; Latagliata R; Bucelli C; Castagnetti F; Breccia M; Abruzzese E; Cattaneo D; Fava C; Ferrero D; Gozzini A; Bonifacio M; Tiribelli M; Pregno P; Stagno F; Vigneri P; Annunziata M; Cavazzini F; Binotto G; Mansueto G; Russo S; Falzetti F; Montefusco E; Gugliotta G; Storti S; D'Addosio AM; Scaffidi L; Cortesi L; Cedrone M; et alii...

Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines. in Oncotarget / Oncotarget. 2016 Nov 22;7(47):76577-76589. doi: 10.18632/oncotarget.10428.

2016
AOU San Luigi di Orbassano

Monica V; Lo Iacono M; Bracco E; Busso S; Di Blasio L; Primo L; Peracino B; Papotti M; Scagliotti G;

CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype. in Oncotarget / Oncotarget. 2015 Oct 6;6(30):29626-36. doi: 10.18632/oncotarget.4988.

2015
AOU San Luigi di Orbassano

Duregon E; Senetta R; Pittaro A; Verdun di Cantogno L; Stella G; De Blasi P; Zorzetto M; Mantovani C; Papotti M; Cassoni P;

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma. in Oncotarget / Oncotarget. 2015 May 20;6(14):12783-95. doi: 10.18632/oncotarget.3727.

2015
AOU San Luigi di Orbassano

Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.

2015
AOU San Luigi di Orbassano

Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. in Oncotarget / Oncotarget. 2014 Aug 15;5(15):6191-205. doi: 10.18632/oncotarget.2186.

2014
AOU San Luigi di Orbassano
AOU Alessandria

Volante M; Funaro A; Rapa I; Righi L; Ruffini E; Novello S; Orecchia S; Ferrero E; Scagliotti G; Martinetto F; Morone S; Lo Buono N; Ortolan E; Giacomino A;